Testing Seralutinib with Gereic Dry Powder Inhaler for pulmonary arterial hypertension
Explore this study →
Everyone in this study receives Seralutinib, together with one or more of: Gereic Dry Powder Inhaler.
Sites in Calgary, London and 2 more cities
- Phase 3
- 1 group
- Sites in Calgary, London and 2 more cities
- Recruiting
Official title: Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Pulmonary Arterial Hypertension · Gossamer Bio USA, Inc.